	US 12,257,231 B2
	Method and composition for preventing and treating viral infections
Daryl L. Thompson, Winter Haven, FL (US)
Assigned to Global BioLife Inc., Bethesda, MD (US)
Filed by Global BioLife Inc., Bethesda, MD (US)
Filed on Jun. 14, 2021, as Appl. No. 17/346,569.
Application 17/346,569 is a continuation in part of application No. 16/544,308, filed on Aug. 19, 2019, granted, now 11,033,528, issued on Jun. 15, 2021.
Application 16/544,308 is a continuation of application No. 15/043,472, filed on Feb. 12, 2016, granted, now 10,383,842, issued on Aug. 20, 2019.
Claims priority of provisional application 62/115,983, filed on Feb. 13, 2015.
Prior Publication US 2021/0299088 A1, Sep. 30, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/352 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/353 (2006.01); A61K 31/4453 (2006.01); A61K 47/16 (2006.01); A61K 47/22 (2006.01); A61P 31/16 (2006.01)

CPC A61K 31/352 (2013.01) [A61K 9/0019 (2013.01); A61K 9/2013 (2013.01); A61K 9/4858 (2013.01); A61K 31/353 (2013.01); A61K 31/4453 (2013.01); A61K 47/16 (2013.01); A61K 47/22 (2013.01); A61P 31/16 (2018.01)]

11 Claims

1. A method of limiting the occurrence of, reducing the risk or severity of or treating a viral infection, the method comprising administering a composition comprising therapeutically effective amounts of myricetin and hesperidin to a patient at risk of or diagnosed with the viral infection selected from the group consisting of influenza, Ebola, and rhinovirus.